🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Inves...
Status
Recruiting
Location
Laboratory for Muscle Diseases and Neuropathies
Start Date
2025-02-13
Trial ID
NCT06523400
Treatments Being Tested
This is a phase II randomized, observer-blinded, placebo-controlled study w...
Status
Recruiting
Location
The Aga Khan University
Start Date
2024-05-02
Trial ID
NCT05808166
The primary objective is to determine if the addition of a 12-week course o...
Status
Terminated
Location
University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center
Start Date
2023-07-25
Trial ID
NCT05306353
Treatments Being Tested
This is a placebo controlled randomised clinical trial.Patients attending Y...
Status
Completed
Location
Chapel Allerton Hospital
Start Date
2006-09
Trial ID
NCT01308255
Treatments Being Tested
This international, multi-centre, double-blind vaccine study is a three-arm...
Status
Completed
Location
MRC/UVRI and LSHTM Uganda Research Unit
Start Date
2020-12-15
Trial ID
NCT04066881
Treatments Being Tested
The prevalence of Alzheimer's Disease (AD) is rising, but existing medicati...
Status
Completed
Location
Albert Einstein College of Medicine
Start Date
2021-03-25
Trial ID
NCT04404153
This was a multicenter, randomized, double-blind, placebo-controlled, paral...
Status
Completed
Location
Research site
Start Date
2013-07-29
Trial ID
NCT01919164
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of guselkumab...
Status
Terminated
Location
University of Kansas Medical Center
Start Date
2020-12-10
Trial ID
NCT04633447
Treatments Being Tested
This is a multi-center, Phase 2 trial of ublituximab as first-line combinat...
Status
Recruiting
Location
University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology
Start Date
2026-04-21
Trial ID
NCT07103746
Treatments Being Tested
This is a clinical proof-of-concept (PoC) study of DNA vaccination after SA...
Status
Completed
Location
National Amyloidosis Centre
Start Date
2013-10
Trial ID
NCT02425241